Adverum Biotechnologies Inc. sell StockNews.com
Start price
19.12.24
/
50%
€1.38
Target price
19.12.25
-
Performance (%)
-
End price
20.12.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Adverum Biotechnologies Inc. | - | - | - |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% |
Comments by StockNews_com for this prediction
In the thread Adverum Biotechnologies Inc. diskutieren
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ADVM provided by MarketBeat
In the thread Trading Adverum Biotechnologies Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€0.73
13.05.23
13.05.23
-
13.05.24
13.05.24
102.74%
14.05.24
14.05.24
